Although we do not see enhanced tumor growth mediated by cdr2 in EL4 tumor cells, a random screen for focus-forming genes in NIH3T3 cells [54] categorized cdr2 as “moderately” oncogenic. This evidence concerns the gene CDR2 and neoplasm.